Traffic Roots Audience Pixel
Protectx

A safer future isn’t just something we wish for.

We’re creating it.

OUR MISSION:
TO DELIVER NEXT-GEN ARRAYS FOR BETTER HEALTH AND SAFETY.
State-Of-Art Performance
DNA and RNA-based pathogen testing kits from PathogenDx are light years ahead of other microbial testing methods. In addition to being able to test for dozens of different microbials simultaneously, testing kits from PathogenDx provide:
Ultra-Rapid
The PathogenDx Microarray platform enables high-specificity detection of a broad range microbial threats, in a single test, in less than 6 hours from new sample to result.
Scalable. Unbeatable.
Forget the one and done. The PathogenDx Microarray iinterrogates dozens of threats in a single test—with rapid adaptability—helping labs drive unprecedented throughput.
Automated Prep
Our latest innovation, Octa AutoPrep Station, delivers “set it and forget it” ease for sample prep, reducing hands-on steps, time to results and the potential for human error.
Lowest Cost
Given the dramatic efficiencies of our platform, and the addition of new automated sample prep, PathogenDx is driving down the cost of every single test and every lab process.
Maximum Detection
If it’s there, we’ll identify it, with detection and quantification down to 1CFU/gram for pathogenic organisms.
Consumables Down, ROI Up
Unlike other technologies, we’ve simplified sample prep. One sample prep for all assays, reducing the cost and environmental waste of consumables.
WE ARE A TEAM OF PASSIONATE MOLECULAR SCIENTISTS COLLABORATING TO DESIGN TESTING SYSTEMS BASED ON OUR WORLD-CLASS MICROARRAY TECHNOLOGY.
WE DELIVER MOLECULAR ASSAYS THAT INTERROGATE MULTIPLE TARGETS IN THE SAME REACTION ACROSS SAMPLE TYPES
OUR ASSAYS DELIVER SINGLE GENE COPY SENSITIVITY, AND SINGLE NUCLEOTIDE RESOLUTIONS.
How the multiplex works
Zooming graphic of the technology inside the PathogenDx Microarray.
A sample goes through hybridization inside a PathogenDX Microarray.
The sample is scanned, illuminating the florescent dye.
Safer Every Day: Updates
  • WHITEPAPER – A New Approach: UTI Detection + Antibiotic Resistance in a Rapid Affordable Test

    Treatment of Urinary Tract Infections is time-consuming, taking anywhere from 2-5 days if antibiotic resistance genes are also tested. When misdiagnosed and further treatment becomes necessary, costs become unmanageable. PathogenDx D3 Array™-UTI is a fast multiplexed platform for urinary pathogen detection run simultaneously with Antibiotic Resistance genes to support clinicians in delivering rapid UTI treatment and management. This test provides:

    ▪ More flexible, faster and lower cost test than qPCR or NGS technology

    ▪ Testing for all targets of interest

    ▪ Each sample analyzed in triplicate for Quality Assurance

    ▪ 3D cross-linked array architecture enabling rapid binding

    ▪ Based on our patented technology

    Read the the more thorough technical breakdown in the whitepaper from Dr. Sue Evans here.

    More »
  • SNAPSHOT: WHY NOVEL MULTIPLEXED MOLECULAR DIAGNOSTICS MATTERS?

    Today, across clinical testing demands, there are instances where diagnostic pathogen testing conducted through well-known qPCR (quantitative polymerase chain reaction) and NGS (next-generation genomic sequencing) can be better addressed by new technology. PathogenDx innovation has produced Dynamic Dimensional Detection through its novel D3 Array™ platform. 

    How does this third path to insight that address sensitivity and multiplex limitation of qPCR and improve on the cost and timeliness of NGS? Download our Innovation Snapshot for a quick overview of this breakthrough technology. Better still, reach out to arrange a technical webinar for how assays designed upon the D3 Array™ are driving laboratory efficiencies, reducing cost and waste, and showing the way to improve lab testing economics.

    Download infographic here >>>

    More »
The future of safe
Learn more about PathogenDx and the Future of Safe: